IMVT Message Board Post 10022692 | Immunovant Inc.
home / stock / imvt / imvt message board
Nlv1980
(investorshub)
Posted on: Mar/08/2021 14:26:58
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162401379
Immunovant shares are trading higher after Roivant Sciences
News, Short Squeeze, Breakout and More Instantly...
-
2024-06-12 13:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year ending March 31, 2025 Topline data from the bato...
-
2024-05-29 14:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for IMVT on May 29, 2024 12:26PM ET. The previous analyst recommendation was Neutral. IMVT was trading at $30.615 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...